A few other KEYS re: the Bruce Patterson presentation on TED ... and an "also ran"
1. This was TED. I believe TED presentations are generally very credible, unique, concise, and have a certain implied importance simply by being on TED. Also the TED audience is one worth reaching. This isn't the kind of program you see in a raucous barroom with six other TVs blaring - it's one that's actually being listened to - and I suspect some of the audience took notice!
2. The focus beyond the disease, process, and mortality to the seldom mentioned dark topic of morbidity was another key. Sure not that many die (currently 12%), but "recovering [or not being dead] is sometimes accompanied by all kinds of lingering problems. Thanks to BP for bringing this into the limelight - not everyone is fortunate to survive the disease and gallop off, smiling into the sunset.
3. The objective evaluation of the efficacy of Remdesivir and (drum roll....trumpets....) the new, inexpensive wonder drug...Dexamethasone . He definitely injected some badly need clarity into the debate. ..And clearly delineated the superiority of leronlimab!!!
(the next part has nothing to do with Bruce Patterson's presentation)
4. Awkward Question - are we "loyal shareholders" going to be somewhere in line to get this drug if we need it? ...or will we have to isolate for a few more years?
Market Data 
Markets 
AI
